Russel Pike

484 total citations
4 papers, 93 citations indexed

About

Russel Pike is a scholar working on Infectious Diseases, Pharmacology and Organic Chemistry. According to data from OpenAlex, Russel Pike has authored 4 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pharmacology and 1 paper in Organic Chemistry. Recurrent topics in Russel Pike's work include Bioactive Compounds and Antitumor Agents (1 paper), Hepatitis B Virus Studies (1 paper) and Asymmetric Synthesis and Catalysis (1 paper). Russel Pike is often cited by papers focused on Bioactive Compounds and Antitumor Agents (1 paper), Hepatitis B Virus Studies (1 paper) and Asymmetric Synthesis and Catalysis (1 paper). Russel Pike collaborates with scholars based in United States. Russel Pike's co-authors include Viyyoor Girijavallabhan, Yi‐Tsung Liu, Anil K. Saksena, Ashit K. Ganguly, Haiyan Wang, Raymond G. Lovey, David Loebenberg, James J. Kaminski, Arthur J. Elliott and Raulo Parmegiani and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Russel Pike

4 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Russel Pike United States	4	61	29	22	18	7	4	93
Yi‐Tsung Liu United States	5	51 0.8×	36 1.2×	18 0.8×	17 0.9×	8 1.1×	9	88
Edwin Jao United States	7	54 0.9×	28 1.0×	28 1.3×	22 1.2×	6 0.9×	12	100
Sony Agrawal United States	8	63 1.0×	52 1.8×	46 2.1×	24 1.3×	9 1.3×	12	163
Vinay Girijavallabhan United States	6	99 1.6×	29 1.0×	25 1.1×	9 0.5×	7 1.0×	12	144
Richard D. Kelsey United Kingdom	6	138 2.3×	47 1.6×	23 1.0×	39 2.2×	11 1.6×	8	204
Honggun Lee South Korea	8	53 0.9×	61 2.1×	25 1.1×	26 1.4×	7 1.0×	14	159
Brian Ledford United States	5	108 1.8×	50 1.7×	9 0.4×	20 1.1×	17 2.4×	6	147
Benedetta Crescenzi Italy	6	58 1.0×	39 1.3×	52 2.4×	11 0.6×	3 0.4×	8	105
Frank Ruebsam China	7	116 1.9×	106 3.7×	32 1.5×	12 0.7×	6 0.9×	13	205
Yi-Fei Gong United States	4	79 1.3×	20 0.7×	60 2.7×	15 0.8×	4 0.6×	4	139

Countries citing papers authored by Russel Pike

Since Specialization

Citations

This map shows the geographic impact of Russel Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russel Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russel Pike more than expected).

Fields of papers citing papers by Russel Pike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russel Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russel Pike. The network helps show where Russel Pike may publish in the future.

Co-authorship network of co-authors of Russel Pike

This figure shows the co-authorship network connecting the top 25 collaborators of Russel Pike. A scholar is included among the top collaborators of Russel Pike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russel Pike. Russel Pike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Nair, Latha G., Stéphane Bogen, Sumei Ruan, et al.. (2010). Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1689–1692. 7 indexed citations

2.

Bennett, Frank, Anil K. Saksena, Raymond G. Lovey, et al.. (2005). Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]. Bioorganic & Medicinal Chemistry Letters. 16(1). 186–190. 23 indexed citations

3.

Saksena, Anil K., Viyyoor Girijavallabhan, Haiyan Wang, et al.. (1996). Concise asymmetric routes to 2,2,4-trisubstituted tetrahydrofurans via chiral titanium imide enolates: Key intermediates towards synthesis of highly active azole antifungals SCH 51048 and SCH 56592. Tetrahedron Letters. 37(32). 5657–5660. 35 indexed citations

4.

Lovey, Raymond G., Arthur J. Elliott, James J. Kaminski, et al.. (1992). Isobenzofurans as conformationally constrained miconazole analogs with improved antifungal potency. Journal of Medicinal Chemistry. 35(22). 4221–4229. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact